These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9116404)

  • 1. [The human immunodeficiency virus. In search of an effective prophylaxis].
    Ciufecu C
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):147-50. PubMed ID: 9116404
    [No Abstract]   [Full Text] [Related]  

  • 2. Outwitting HIV: Minnesota researchers take on a clever virus.
    Bell H
    Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-1 therapeutic vaccines.
    Kinloch-de Loes S; Autran B
    J Infect; 2002 Apr; 44(3):152-9. PubMed ID: 12099741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV genetic diversity and its consequences].
    Roquebert B; Damond F; Brun-Vézinet F; Descamps D
    Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies to combat HIV: augmenting antiviral immunity.
    Smith KA; Boyle BA
    AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
    [No Abstract]   [Full Text] [Related]  

  • 6. In search of a human immunodeficiency virus vaccine.
    Bartholomew CF
    West Indian Med J; 2000 Sep; 49(3):187-9. PubMed ID: 11076204
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrovirus meeting. HIV/AIDS researchers reach for high-hanging fruit.
    Cohen J
    Science; 2009 Feb; 323(5917):996-7. PubMed ID: 19229005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surfactants as agents for the individual prevention of HIV/AIDS].
    Krivorutchenko IuL
    Mikrobiol Z; 1999; 61(1):95-103. PubMed ID: 10330875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking HIV entry.
    Buzko OV; Shokat KM
    Nat Struct Biol; 1999 Oct; 6(10):906-8. PubMed ID: 10504719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
    Das AT; Zhou X; Vink M; Klaver B; Berkhout B
    Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.
    Ensoli B; Cafaro A
    AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215
    [No Abstract]   [Full Text] [Related]  

  • 13. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
    [No Abstract]   [Full Text] [Related]  

  • 14. Key issues for a potential human immunodeficiency virus vaccine.
    Hu DJ; Vitek CR; Bartholow B; Mastro TD
    Clin Infect Dis; 2003 Mar; 36(5):638-44. PubMed ID: 12594646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years of HIV-1 research: what the future holds.
    Imami N; Gotch F
    Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 17. No vaccine against HIV yet--are we not perfectly equipped?
    Singh M
    Virol J; 2006 Aug; 3():60. PubMed ID: 16939652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial suggests vaccines could aid HIV therapy.
    Check E
    Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK
    J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.